Groups | Baseline | Reperfusion, min |
---|
| | 5 | 30 | 60 | 120 |
CON-22 (n=7) | 11.9±2.3 | 3.8±1.5 | 5.4±1.6 | 6.5±1.9 | 5.8±2.6 |
mKHB-22 (n=7) | 10.2±2.6 | 4.5±2.3 | 6.7±1.6 | 6.1±1.8 | 4.2±1.7 |
STH2-22 (n=6) | 13.2±3.5 | 5.3±2.5 | 6.7±2.2 | 7.5±4.6 | 5.5±2.1 |
CON-37 (n=7) | 12.4±3.2 | 4.1±1.3 | 4.3±1.9 | 4.1±1.7 | 3.8±1.2 |
mKHB-37 (n=5) | 10.4±1.9 | 6.6±4.0 | 6.2±1.7 | 6.3±0.6 | 5.2±1.4 |
STH2-37 (n=6) | 11.2±1.8 | 5.6±3.9 | 4.6±2.1 | 3.3±0.7 | 3.1±0.9 |
- Data are mean ± SD. Group legends in hypothermia series: controls subjected to 180-min ischemia and 120-min reperfusion (CON-22), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-22), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-22). Group legends in normothermia series: controls subjected to 60-min ischemia and 120-min reperfusion (CON-37), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-37), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-37).